There is usually a difference in the amount and level of evidence and data submitted to the FDA for seeking normal approval versus emergency-use approval. My one reservation will probably not apply to me, but rather to anyone offered a vaccine during the current administration. Atula Gawande, author of
Being Mortal, recently mentioned here in the Fourm, happened to be on TV this morning and was asked this very question. He said current FDA personnel have stated emphatically that they will not be influenced by political pressure in deciding on emergency-use approval of any Covid-19 vaccine, and Gawande said we should gain additional trust when we see doctors and nurses getting vaccinated in this period.
As I mentioned in another post, it may be that rare adverse events occurring, say, 1 in 200,000 vaccinations are not revealed until massive vaccination is underway simply because the phase 3 trials have just tens of thousands of subjects.
I think that by the time I'm offered a vaccine, experts outside the FDA, as well as in the new admin. will have reviewed the data, and I won't have any hesitations.
From what I'm reading, for, example, it's possible that remdesivir may have its emergency-use approval withdrawn and not be granted regular approval for the indication of Covid-19. {Edit: I was certainly wrong about
this -- it got full approval on Oct 22.]
Djin
Post Edited (DjinTonic) : 11/17/2020 8:04:37 AM (GMT-7)